GO
Loading...

Lightning Round: Solazyme, Allot Comm. & More

Are you ready skeedaddy? It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Solazyme (SZYM): This stock is too speculative for me, said Cramer. There are just too many other places to put money to work that are better.


Allot Communications (ALLT): If you're long, I wouldn't sell, said Cramer. It's just too low here.

Teva Pharmaceuticals (TEVA): I'm a seller, said Cramer. I find this stock simply too hard to own.


Vasiliki Varvaki | E+ | Getty Images

Harvest Natural Resources (HNR): In this space I'd much rather put money in Chevron.

Energy Transfer Partners (ETP): My charitable trust owns this stock, admitted Cramer, but it's the worst stock.




Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
SOLAZYME
---
ALLT
---
TEVA
---
HNR
---
ETP
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.